View ValuationKNC Laboratories 향후 성장Future 기준 점검 0/6현재 KNC Laboratories 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.핵심 정보n/a이익 성장률n/aEPS 성장률Chemicals 이익 성장14.0%매출 성장률n/a향후 자기자본이익률n/a애널리스트 커버리지None마지막 업데이트n/a최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.공시 • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).공시 • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026공시 • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).공시 • Jun 04KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025공시 • May 13KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025.Upcoming Dividend • Mar 21Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).공시 • Feb 28KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025공시 • Jan 17KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025Upcoming Dividend • Sep 20Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%).공시 • Aug 24KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m).공시 • May 25KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).공시 • Mar 15KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.공시 • Mar 02KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024공시 • Nov 19KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024Upcoming Dividend • Sep 21Inaugural dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%.공시 • Aug 19KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023공시 • Jun 03KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023공시 • May 14KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023.Upcoming Dividend • Mar 23Inaugural dividend of JP¥18.00 per shareEligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%.공시 • Dec 17KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 01KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022공시 • Jun 02KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022공시 • May 18KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 08KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Upcoming Dividend • Mar 23Inaugural dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%.공시 • Mar 05KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021Is New 90 Day High Low • Feb 15New 90-day low: JP¥1,526The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.공시 • Dec 12KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021공시 • Sep 13KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020공시 • Jun 29KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020이익 및 매출 성장 예측TSE:6568 - 애널리스트 향후 추정치 및 과거 재무 데이터 (JPY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/20249,3001,470N/AN/A13/31/20164,612391N/AN/AN/A애널리스트 향후 성장 전망수입 대 저축률: 6568 의 예상 수익 증가율이 절약률(0.8%)보다 높은지 판단하기에는 데이터가 부족합니다.수익 vs 시장: 6568 의 수익이 JP 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.고성장 수익: 6568 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.수익 대 시장: 6568 의 수익이 JP 시장보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.고성장 매출: 6568 의 수익이 연간 20%보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 6568의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 03:09종가2026/05/20 00:00수익2016/03/31연간 수익2016/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스KNC Laboratories Co., Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Masao YoshidaIchiyoshi Research Institute Inc.
공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.
공시 • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
공시 • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026
공시 • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025
Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).
공시 • Jun 04KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025
공시 • May 13KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).
공시 • Feb 28KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025
공시 • Jan 17KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025
Upcoming Dividend • Sep 20Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%).
공시 • Aug 24KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024
New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m).
공시 • May 25KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024
공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).
공시 • Mar 15KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.
공시 • Mar 02KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024
공시 • Nov 19KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024
Upcoming Dividend • Sep 21Inaugural dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%.
공시 • Aug 19KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023
공시 • Jun 03KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023
공시 • May 14KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023.
Upcoming Dividend • Mar 23Inaugural dividend of JP¥18.00 per shareEligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%.
공시 • Dec 17KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 01KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022
공시 • Jun 02KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022
공시 • May 18KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 08KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Upcoming Dividend • Mar 23Inaugural dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%.
공시 • Mar 05KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021
Is New 90 Day High Low • Feb 15New 90-day low: JP¥1,526The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
공시 • Dec 12KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021
공시 • Sep 13KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020
공시 • Jun 29KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020